The chemical substance "H-Lys-Arg-Thr-Leu-Arg-OH," with the CAS number 121145-48-0, is a synthetic peptide composed of five amino acids: lysine (Lys), arginine (Arg), threonine (Thr), leucine (Leu), and another arginine. This peptide is characterized by its specific sequence, which influences its biological activity and interactions. Peptides like this one often exhibit properties such as solubility in water, stability under physiological conditions, and the ability to interact with various biological receptors or enzymes. The presence of basic amino acids like lysine and arginine may contribute to its positive charge at physiological pH, potentially enhancing its binding affinity to negatively charged biomolecules. Additionally, the sequence and structure can affect its conformation, stability, and overall functionality in biological systems. Peptides are widely studied for their roles in signaling, therapeutic applications, and as potential drug candidates due to their specificity and lower toxicity compared to traditional small-molecule drugs.

H-Lys-Arg-Thr-Leu-Arg-OH

121145-48-0: The chemical substance "H-Lys-Arg-Thr-Leu-Arg-OH," with the CAS number 121145-48-0, is a synthetic peptide composed of five amino acids: lysine (Lys), arginine (Arg), threonine (Thr), leucine (Leu), and another arginine. This peptide is characterized by its specific sequence, which influences its biological activity and interactions. Peptides like this one often exhibit properties such as solubility in water, stability under physiological conditions, and the ability to interact with various biological receptors or enzymes. The presence of basic amino acids like lysine and arginine may contribute to its positive charge at physiological pH, potentially enhancing its binding affinity to negatively charged biomolecules. Additionally, the sequence and structure can affect its conformation, stability, and overall functionality in biological systems. Peptides are widely studied for their roles in signaling, therapeutic applications, and as potential drug candidates due to their specificity and lower toxicity compared to traditional small-molecule drugs.

H-Lys-Arg-Thr-Leu-Arg-OH is a synthetic substrate that inhibits the enzyme adriamycin phosphatase, which is involved in the catalytic mechanism of adriamycin. It has potent inhibitory activity against the enzyme and was found to be more potent than Adriamycin in binding to and inhibiting protein synthesis. H-Lys-Arg-Thr-Leu-Arg-OH has been shown to phosphorylate proteins by an unknown mechanism. This compound also has an analog that displays similar inhibitory properties, but with a different affinity for the il2 receptor.

CAS 121145-48-0

H-Lys-Arg-Thr-Leu-Arg-OH

H-Lys-Arg-Thr-Leu-Arg-OH

Ref: 3D-FL110901